“Pharmacological Blockade of Protease-Activated Receptor 2 Improves Airway Remodeling and Lung Inflammation in Experimental Allergic Asthma”. Brazilian Journal of Pharmaceutical Sciences 58 (February 6, 2023). Accessed June 10, 2024. https://periodicos.usp.br/bjps/article/view/207714.